Duration of Escitalopram Treatment After Symptom Improvement

Treatment Duration Based on Episode History

For a first episode of major depression, the American Academy of Pediatrics recommends continuing escitalopram for 4-9 months after achieving remission to prevent relapse 1, 4
For patients with 2 or more previous episodes, the American Academy of Pediatrics suggests extending treatment duration to years or lifelong due to substantially higher recurrence risk 1, 2, 3
The risk of recurrence escalates dramatically: 50% after first episode, 70% after two episodes, and 90% after three episodes 3
Patients should be monitored for up to 2 years given high recurrence rates in those with recurrent depression 1

The American Academy of Pediatrics states that the greatest relapse risk occurs in the first 8-12 weeks after discontinuation, requiring intensive monitoring during this period 1
Close follow-up should be maintained for at least 2-3 months after stopping the antidepressant 1
The American Academy of Pediatrics recommends assessing patients in person within 1 week of treatment initiation 1
Continue monthly monitoring for 6-12 months after full symptom resolution 1, 2
At each visit, evaluate: ongoing depressive symptoms, suicide risk, adverse effects, treatment adherence, and environmental stressors 1, 2

The American Academy of Pediatrics advises against discontinuing treatment prematurely when initial symptoms improve, as this dramatically increases relapse risk 2, 3
Reassess if no improvement occurs after 6-8 weeks and consider mental health consultation 1, 5, 2

Monitor closely for 2-3 months post-discontinuation as this is the highest-risk period for relapse 1